Roche’s Ebola Test Gets FDA’s Emergency Use Authorization
Roche ( RHHBY ) announced that the FDA has granted Emergency Use Authorization for the LightMix Ebola Zaire rRT-PCR Test. The test is allowed for use in patients showing signs and symptoms of Ebola Zaire virus infection in combination with epidemiological risk factors, such as individuals traveling from West Africa. The test is able to detect the Ebola Zaire virus in whole blood samples using the large installed base of Roche's LightCycler 480 or cobas z 480 instruments […]